Cargando…
Hypersensitivity to oxaliplatin: clinical features and risk factors
BACKGROUND: Oxaliplatin-based regimens induce a potential risk of hypersensitivity reaction (HSR), with incidence varying from 10% to 25% and lack of clearly identified risk factors. The present study aimed to assess incidence and risk factors in HSR. METHODS: All patients treated with oxaliplatin i...
Autores principales: | Parel, Marie, Ranchon, Florence, Nosbaum, Audrey, You, Benoit, Vantard, Nicolas, Schwiertz, Vérane, Gourc, Chloé, Gauthier, Noémie, Guedat, Marie-Gabrielle, He, Sophie, Kiouris, Eléna, Alloux, Céline, Vial, Thierry, Trillet-Lenoir, Véronique, Freyer, Gilles, Berard, Frédéric, Rioufol, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3896838/ https://www.ncbi.nlm.nih.gov/pubmed/24417770 http://dx.doi.org/10.1186/2050-6511-15-1 |
Ejemplares similares
-
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
por: Ranchon, Florence, et al.
Publicado: (2011) -
Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects
por: Périchou, Juliette, et al.
Publicado: (2020) -
Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods
por: Bourmaud, Aurélie, et al.
Publicado: (2015) -
Assessment of Patient Reported Outcomes (PROs) in Outpatients Taking Oral Anticancer Drugs Included in the Real-Life Oncoral Program
por: Collomb, Bastien, et al.
Publicado: (2022) -
Pandémie à SARS-COV-2 : implication du pharmacien hospitalier dans la sécurisation de la prise en charge des patients
por: Baudouin, Amandine, et al.
Publicado: (2023)